Latest news
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:00:00 GMTRemote biophysical profile, contraceptive patch efficacy explained, FQHC prenatal care gaps - Contemporary OB/GYNContemporary OB/GYN · Fri, 07 Aug 2026 18:53:49 GMT